- Home
- TALK vs EBS Comparison
TALK vs EBS Comparison
Compare TALK & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- EBS
- Stock Information
- Founded
- TALK 2012
- EBS 1998
- Country
- TALK United States
- EBS United States
- Employees
- TALK N/A
- EBS N/A
- Industry
- TALK Medical/Nursing Services
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- TALK Health Care
- EBS Health Care
- Exchange
- TALK Nasdaq
- EBS Nasdaq
- Market Cap
- TALK 435.4M
- EBS 359.3M
- IPO Year
- TALK N/A
- EBS 2006
- Fundamental
- Price
- TALK $2.80
- EBS $9.23
- Analyst Decision
- TALK Buy
- EBS Strong Buy
- Analyst Count
- TALK 6
- EBS 3
- Target Price
- TALK $4.50
- EBS $14.33
- AVG Volume (30 Days)
- TALK 1.6M
- EBS 1.5M
- Earning Date
- TALK 08-05-2025
- EBS 08-06-2025
- Dividend Yield
- TALK N/A
- EBS N/A
- EPS Growth
- TALK N/A
- EBS N/A
- EPS
- TALK 0.02
- EBS 2.53
- Revenue
- TALK $202,611,000.00
- EBS $851,600,000.00
- Revenue This Year
- TALK $21.98
- EBS N/A
- Revenue Next Year
- TALK $20.60
- EBS $14.20
- P/E Ratio
- TALK $165.52
- EBS $3.65
- Revenue Growth
- TALK 17.43
- EBS N/A
- 52 Week Low
- TALK $1.70
- EBS $4.02
- 52 Week High
- TALK $4.36
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- TALK 63.99
- EBS 68.42
- Support Level
- TALK $2.53
- EBS $8.91
- Resistance Level
- TALK $2.53
- EBS $9.43
- Average True Range (ATR)
- TALK 0.12
- EBS 0.59
- MACD
- TALK 0.04
- EBS 0.15
- Stochastic Oscillator
- TALK 95.87
- EBS 88.89
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.